genetically engineered mouse
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
13
Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN -deficient prostate cancer
18
Genetically engineered mouse models and human osteosarcoma
14
Hormone induced protection of mammary tumorigenesis in genetically engineered mouse models
11
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models
13
Capturing the Molecular and Biological Diversity of High-Grade Astrocytoma in Genetically Engineered Mouse Models
11
Delivery strategies of cancer immunotherapy: recent advances and future perspectives
14
Targeting of interleukin 13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF β and PTEN signaling
11
SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG
7
DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways
17
Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future
11
PubMedCentral-PMC5070672.pdf
12
Mouse models of breast cancer in preclinical research
6
Mouse models of liver cancer: Progress and recommendations
17
TarGo: network based target gene selection system for human disease related mouse models
7
Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer
12
Genes and physiology: molecular physiology in genetically engineered animals
10
Genetically engineered nanocarriers for drug delivery
10
Pharmacology of Recombinant or Genetically Engineered Drugs
10
Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells
20